Literature DB >> 11170730

Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin.

J F Hamilton1, P F Morrison, M Y Chen, J Harvey-White, R S Pernaute, H Phillips, E Oldfield, K S Bankiewicz.   

Abstract

Convection-enhanced delivery (CED) distributes macromolecules in the brain in a homogeneous, targeted fashion in clinically useful volumes. However, the binding of growth factors to heparin-binding sites in the extracellular matrix may limit the volume of distribution (V(d)). To overcome this limitation, we examined the effects of heparin coinfusion on V(d) of glial-derived neurotrophic factor (GDNF), neurturin (NTN), artemin, and a nonspecifically bound protein, albumin. Heparin coinfusion significantly enhanced the V(d) of GDNF and GDNF-homologous trophic factors, probably by binding and blocking heparin-binding sites in the extracellular matrix. Furthermore, coinfusion of heparin with NTN enhanced striatal dopamine metabolism, compared to trophic factor administered alone. The negligible benefit of GDNF in recent clinical trials of Parkinson's disease may result from limited tissue distribution. Heparin coinfusion during CED targeting the striatum may alleviate this important limitation. This study demonstrates the influence of receptor binding on the distribution of trophic factors in the CNS. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170730     DOI: 10.1006/exnr.2000.7571

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  38 in total

1.  Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.

Authors:  Wayne A Cass; Laura E Peters
Journal:  Neurochem Int       Date:  2010-07-06       Impact factor: 3.921

Review 2.  Real-time imaging and quantification of brain delivery of liposomes.

Authors:  Michal T Krauze; John Forsayeth; John W Park; Krystof S Bankiewicz
Journal:  Pharm Res       Date:  2006-09-14       Impact factor: 4.200

3.  In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine system.

Authors:  E M Torres; C Monville; P R Lowenstein; M G Castro; S B Dunnett
Journal:  Brain Res Mol Brain Res       Date:  2005-04-18

4.  The first cysteine-rich domain of the receptor GFRalpha1 stabilizes the binding of GDNF.

Authors:  Heidi Virtanen; Jianmin Yang; Maxim M Bespalov; Jukka O Hiltunen; Veli-Matti Leppänen; Nisse Kalkkinen; Adrian Goldman; Mart Saarma; Pia Runeberg-Roos
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

5.  Real-time MR imaging of adeno-associated viral vector delivery to the primate brain.

Authors:  Massimo S Fiandaca; Vanja Varenika; Jamie Eberling; Tracy McKnight; John Bringas; Phillip Pivirotto; Janine Beyer; Piotr Hadaczek; William Bowers; John Park; Howard Federoff; John Forsayeth; Krystof S Bankiewicz
Journal:  Neuroimage       Date:  2008-11-27       Impact factor: 6.556

Review 6.  Diffusion in brain extracellular space.

Authors:  Eva Syková; Charles Nicholson
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

Review 7.  Trophic factors therapy in Parkinson's disease.

Authors:  Shilpa Ramaswamy; Katherine E Soderstrom; Jeffrey H Kordower
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

8.  Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents.

Authors:  Michal T Krauze; Ryuta Saito; Charles Noble; Matyas Tamas; John Bringas; John W Park; Mitchel S Berger; Krystof Bankiewicz
Journal:  J Neurosurg       Date:  2005-11       Impact factor: 5.115

9.  Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS.

Authors:  Jerusha Naidoo; Lisa M Stanek; Kousaku Ohno; Savanah Trewman; Lluis Samaranch; Piotr Hadaczek; Catherine O'Riordan; Jennifer Sullivan; Waldy San Sebastian; John R Bringas; Christopher Snieckus; Amin Mahmoodi; Amir Mahmoodi; John Forsayeth; Krystof S Bankiewicz; Lamya S Shihabuddin
Journal:  Mol Ther       Date:  2018-07-12       Impact factor: 11.454

10.  The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain.

Authors:  Piotr Hadaczek; Yoji Yamashita; Hanna Mirek; Laszlo Tamas; Martha C Bohn; Charles Noble; John W Park; Krystof Bankiewicz
Journal:  Mol Ther       Date:  2006-05-02       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.